Pita Pal Hummus Recall Issued Over Listeria Food Poisoning Concerns

Federal health officials have recalled dozens of hummus products due a listeria food poisoning risk, which may result in serious and potentially life-threatening infections, as well as miscarriages and still births for pregnant women.

The Pita Pal hummus recall was announced by the U.S. Food and Drug Administration (FDA) on July 16, after routine testing discovered the presence of listeria monocytogenes at the company’s production facility. To date, no illnesses or injuries have been reported in relation to the recall.

The recall includes 87 types of hummus products that were sold under the brand names Harris Teeter, Pita Pal, Bucee’s, Fresh Thyme, Hummus Hummus, Lantana, Lidl, Reasor’s, Roundy’s, Schnucks and 7-Select.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The products were manufactured by Pita Pal Foods, LP of Houston, Texas between May 30, 2019 and June 25, 2019, and were distributed to grocery stores including Harris Teeter, Kroger, Food Lion, Lidl, Fresh Market and Target throughout the United States. The products were also distributed to United Arab Emirates customers.

According to the recall, listeria bacteria has not been found in any of the finished hummus products. However, out of an abundance of caution the manufacturer is issuing the recall due to the potential for the infection to have entered the hummus products during production.

Listerosis is a foodborne illness that can cause serious health consequences and death, especially for children, the elderly and those with weakened immune systems. The infection is considered by the FDA as one of the more dangerous foodborne illnesses and frequently results in hospitalizations and carries a 25% fatality rate.

Symptoms of listeria infections may include nausea, muscle ache, diarrhea, fever, and fatigue. In severe cases for the elderly and young children, the bacteria could spread through the bloodstream to the nervous system resulting in sometimes fatal infections. For pregnant women, listerosis can pose a risk of miscarriages, still births, premature delivery or life-threatening infection of the newborn.

Customers are being asked to stop consuming the products immediately and to return them to the place of purchase for a full refund. For additional questions or concerns regarding the recall, customers may contact Pita Pal Foods customer service at 832-803-9295 or email them at products@pitapal.com.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.